Epidemiology of inflammatory bowel disease

Epidemiologic Reviews

Volumn 8, Issue 1, 1986, Pages 60-91

  Calkins, Beverly M ^a   Mendeloff, Albert I ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHILD; CROHN DISEASE; EUROPE; FEMALE; HUMAN; MALE; MIDDLE EAST; MORTALITY; NORTH AMERICA; PRESCHOOL CHILD; REVIEW; SCANDINAVIA; ULCERATIVE COLITIS; UNITED KINGDOM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; EUROPE; FEMALE; GREAT BRITAIN; HUMAN; MALE; MIDDLE EAST; NORTH AMERICA; SCANDINAVIA; SUPPORT, NON-U.S. GOV'T;

EID: 0022456910     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036296     Document Type: Article

References (249)

1. Roth JLA. Diagnosis and differential diagnosis of chronic ulcerative colitis and Crohn’s colitis. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:116-202.
2. Myren J, Bouchier AD, Watkinson G, et al. The OMGE multinational inflammatory bowel disease survey 1976-1982. Scand J Gastroenterol 1984;19(Suppl 95):l-27.
3. Iversen E, Bonnevie O, Anthonisen P, et al. An epidemiological model of ulcerative colitis. Scand J Gastroenterol 1968;3:593-610.
4. Nordenvall B, Brostom O, Burglund M, et al. Incidence of ulcerative colitis in Stockholm county 1955-1979. Scand J Gastroenterol 1985;20:783-90.
5. Hellers G. Crohn’s disease in Stockholm county, 1955-74: a study of epidemiology, results of surgical treatment and long term prognosis. Acta Chir Scand 1979;(Suppl 490):1-84.
6. Sanderson IR, Walker-Smith JA. Indigenous amoebiasis: an important differential diagnosis of chronic inflammatory bowel disease. Br Med J 1984;289:823.
7. Monk M, Mendeloff Al, Siegel Cl, et al. An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. I. Hospital incidence and prevalence, 1960-1963. Gastroenterology 1967;53:198-210.
8. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends in the incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci 1984;29:913-20.
9. Sedlack RE, Nobrega FR, Kurland LT, et al. Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology 1972;62:935-41.
10. Garland CF, Lilienfeld AM, Mendeloff AI, et al. Incidence rates of ulcerative colitis and Crohn’s disease in fifteen areas of the United States. Gastroenterology 1981;81:1115-24.
11. Bonnevie O, Riis P, Anthonisen P. An epidemiological study of ulcerative colitis in Copenhagen county. Scand J Gastroenterol 1968;3:432-8.
12. Binder V, Both H, Hansen PK, et al. Incidence and prevalence of ulcerative colitis and Crohn’s disease in the county of Copenhagen, 1962 to 1978. Gastroenterology 1982;83:563-8.
13. Myren I, Gjone E, Hertzberg JN, et al. Epidemiology of ulcerative colitis and regional enterocolitis (Crohn’s disease) in Norway. Scand J Gastroenterol 1971;6:511-14.
14. Ustvedt JH. Ulcerative colitis: a study of all cases discharged from Norwegian hospitals in the ten- year period 1946-1955. In: Pemberton J, ed. Recent studies in epidemiology. Springfield, IL: Charles C Thomas, 1958:23-34.
15. Morris T, Rhodes J. Incidence of ulcerative colitis in the Cardiff region 1968-1977. Gut 1984;25:846-8.
16. Evans JG, Acheson DE. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford area. Gut 1965;6:311-24.
17. Devlin HB, Datta D, Dellipiani AW. The incidence and prevalence of inflammatory bowel disease in North Tees health district. World J Surg 1980;4:183-93.
18. Nedbal J, Maratka Z. Ulcerative proctocolitis in Czechoslovakia. Am J Proctol 1968;19:106-14.
19. Wigley RD, MacLaurin BP. A study of ulcerative colitis in New Zealand, showing a low incidence in Maoris. Br Med J 1962;2:228-31.
20. Sedlack RE, Whisnant J, Elveback LR, et al. Incidence of Crohn’s disease in Olmsted County, Minnesota, 1945-1975. Am J Epidemiol 1980; 112:759-63.
21. Gelpi A. Inflammatory bowel disease among college students. West J Med 1978;129:369-73.
22. Hoj L, Brix-Jensen P, Bonnevie O, et al. An epidemiological study of regional enteritis and acute ileitis in Copenhagen county. Scand J Gastroenterol 1973;8:381-4.
23. Havia T, Thomasson G. Crohn’s disease: followup study. Acta Chir Scand 1972;138:844-7.
24. Gjone E, Orning OM, Myren J. Crohn’s disease in Norway 1956-1963. Gut 1966;7:372-4.
25. Bergman L, Krause U. The incidence of Crohn’s disease in central Sweden. Scand J Gastroenterol 1975;10:725-9.
26. Norlen BJ, Krause U, Bergman L. An epidemiologic study of Crohn’s disease. Scand J Gastroenterol 1970;5:385-90.
27. Krause U. Epidemiology in Sweden. In: Engel A, Larson T, eds. Regional enteritis (Crohn’s disease). Nordiska Bokhandelns Forlan, Stockholm:Scandia International Symposia, 1971.
28. Kewenter J, Hulten L, Kock NG. The relationship and epidemiology of acute terminal ileitis and Crohn’s disease. Gut 1974;15:801-4.
29. Brahme F, Lindstrom C, Wenckert A. Crohn’s disease in a defined population. Gastroenterology 1975;69:342-51.
30. Harries AD, Baird A, Rhodes J, et al. Has the rising incidence of Crohn’s disease reached a plateau? Br Med J 1982;284:235.
31. Mayberry J, Rhodes J, Hughes LE. Incidence of Crohn’s disease in Cardiff between 1934 and 1977. Gut 1979;20:602-8.
32. Kyle J. An epidemiological study of Crohn’s disease in northeast Scotland. Gastroenterology 1971;61:826-33.
33. Kyle J, Stark G. Fall in the incidence of Crohn’s disease. Gut 1980;21:340-3.
34. Smith IS, Young S, Gillespie G, et al. Epidemiological aspects of Crohn’s disease in Clydesdale 1961-1970. Gut 1975;16:62-7.
35. Humphreys WG, Park TG. Crohn’s disease in Northern Ireland: a retrospective study of 159 cases. Irish J Med Sci 1975;144:437-46.
36. Tresadern JC, Gear MWL, Nicol A. An epidemiological study of regional enteritis in the Gloucester area. Br J Surg 1973;60:366-8.
37. Lee FI, Costello FT. Crohn’s disease in Black pool: incidence and prevalence 1968-80. Gut 1985;26:274-8.
38. Wright JT. The prevalence of Crohn’s disease in an East London borough. Fourth World Congress of Gastroenterology. Advance Abstracts 1970:389.
39. Miller DS, Keighley AC, Langman MJS. Changing patterns in epidemiology of Crohn’s disease.Lancet 1974;2:691-3.
40. Bitter J, Zuvocova J. Crohnova choroba v sev- eroceskem kraji. Cesk Gastroenterol Vyz 1981;35:137-44.
41. Lanfranchi GA, Mechelini A, Brignola C, et al. Uno studio epidemiologico sulle malattie inflam-matorie intestinali nella provincia de Bologna. G Clin Med 1976;57:235-45.
42. Ochoa R. Epidemiologia. In: Fiol M, Ochoa R, Perez P, et al, eds. Simposio sobre la enfermedad de Crohn en Galicia. Rev Esp Enferm Apar Dig 1977;50:469-82.
43. Paredes JG, Garcia JMP. Crohn’s disease in the central area of Spain. In: Pena AS, Weterman IT, Booth CC, et al, eds. Developments in gastroenterology. I. Recent advances in Crohn’s disease. The Hague: Martinus Nijhoff, 1981:168-73.
44. Farhlander H, Baerlocher C. Clinical features and epidemiological data on Crohn’s disease in Basle area. Scand J Gastroenterol 1971;6;657-62.
45. Gilat T, Ribak J, Benaroya Y, et al. Ulcerative colitis in the Jewish population of Tel Aviv-Yafo. I. Epidemiology. Gastroenterology 1974;66:335-42.
46. Gilat T, Rozen P. Epidemiology of Crohn’s disease and ulcerative colitis: etiologic implications. Isr J Med Sci 1979;15:305-8.
47. Krawiec J, Odes HS, Lasry Y, et al. Aspects of the epidemiology of Crohn’s disease in the Jewish population in Beer Sheva, Israel. Isr J Med Sci 1984;20:16-21.
48. Odes HS, Krawiec J, Weitzman S. Prevalence of Crohn’s disease in Israel. N Engl J Med 1982;306:750-1.
49. Rozen P, Zonis J, Yekutiel P, et al. Crohn’s disease in the Jewish population of Tel Aviv- Yafo: epidemiologic and clinical aspects. Gastroenterology 1979;76:25-30.
50. Hutt MSR. Epidemiology of chronic intestinal disease in middle Africa. Isr J Med Sci 1979;15:314-17.
51. Rolon PA. Gastrointestinal pathology in SouthAmerica. Isr J Med Sci 1979;15:318-21.
52. Falla-Alvarez L, Albacete R. Further experience with chronic regional enteritis in Cuba. S Med J 1958;51:1556-61.
53. Jalan KN, Prescott RJ, Sircus W, et al. An experience of ulcerative colitis. III. Long term outcome. Gastroenterology 1970;59:598-609.
54. Moller C, Linden F. Ulcerative colitis in Finland. I. Cases treated at central hospitals, 1956-1967. Dis Colon Rectum 1971;14:259-63.
55. Eason RJ, Lee SP, Tasman-Jones C. Inflammatory bowel disease in Auckland, New Zealand. Aust NZ J Med 1982;12:125-31.
56. Segal I, Tim LO, Hamilton DG, et al. The rarity of ulcerative colitis in South African blacks. Am J Gastroenterol 1980;74:332-6.
57. Ishikawa M, Watanabe H, Yamagishi G, et al. Crohn’s disease, non-specific ulcers of the small intestine, and idiopathic proctocolitis in a Japanese university hospital from 1954 to 1974. Tohoku J Exp Med 1976;118:97-109.
58. Das SK, Montgomery RD. Chronic inflammatory bowel disease in Asian immigrants. Practitioner 1978;221:747-9.
59. Keighley A, Miller DS, Hughes AO, et al. The demographic and social characteristics of patients with Crohn’s disease in the Nottingham area. Scand J Gastroenterol 1976;11:293-6.
60. Brom B, Bank S, Marks IN, et al. Crohn’s disease in the Cape: a follow-up study of 24 cases and a review of the diagnosis and management. S Afr Med J 1968;42:1099-1107.
61. Novis BH, Marks IN, Bank S, et al. Incidence of Crohn’s disease at Groote Schuur Hospital during 1970-1974. S Afr Med J 1975;49:693-7.
62. Goligher JC. Ulcerative colitis. Baltimore: Williams & Wilkins, 1968.
63. Sheps MC. On the person-years concept in epidemiology and demography. Milbank Mem Fund Q 1966;44:68-91.
64. Houghton EAW, Naish JM. Familial ulcerative colitis and regional ileitis. Gastroenterologia 1958;89:65-74.
65. National Center for Health Statistics, Vital Statistics of the United States, 1970. United States Department of Health, Education and Welfare, Public Health Service, Rockville, MD, 1974.
66. National Center for Health Statistics, Vital Statistics of the United States, 1971. United States Department of Health, Education and Welfare, Public Health Service, Rockville, MD, 1974.
67. Mendeloff Al. The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:5-24.
68. Szklo M, Sensenbrenner L, Markowitz J, et al. Incidence of aplastic anemia in metropolitan Baltimore: a population-based study. Blood 1985;66:115-19.
69. Dean G, Kurtzke JF. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 1971;3:725-9.
70. Poskanzer DC, Schapira K, Miller H. Epidemiology of multiple sclerosis in the counties of Northumberland and Durham. J Neurol Neuro-surg Psychiatry 1963;26:368-76.
71. Poskanzer DC, Schapira K, Miller H. Multiple sclerosis and poliomyelitis. Lancet 1963;2:917- 21.
72. Morariu MA, Linden M. Multiple sclerosis in American blacks. Acta Neurol Scand 1980; 62:180-7.
73. Alter M. Multiple sclerosis in the Negro. Arch Neurol 1962;7:83-91.
74. Fischman HR. Multiple sclerosis: a new perspective on epidemiological patterns. Neurology (NY) 1982;32:864-70.
75. Paffenbarger RS, Wing AL, Hyde RT. Brief communication: characteristics in youth indicative of adult-onset Hodgkin’s disease. JNCI 1977; 58:1489-91.
76. Rogers BHG, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 1971;24:743-73.
77. Morson BC. Pathology of ulcerative colitis. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:281-95.
78. Whitehead R. Pathology of Crohn’s disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea & Febiger, 1980:293-307.
79. Burch PRJ, de Dombal FT, Watkinson G. Aetiology of ulcerative colitis. II. A new hypothesis. Gut 1969;10:277-84.
80. Mendeloff AI, Dunn JP. Digestive diseases. American Public Health Association Vital and Health Statistics Monograph. Cambridge, MA: Harvard University Press, 1971.
81. Samuels AD, Weese JL, Berman PM, et al. An epidemiologic and demographic study of inflammatory bowel disease in black patients. Dig Dis Sci 1974;19:156-60.
82. Matsunaga F. Clinical studies of ulcerative colitis and its related diseases in Japan. In: Proceedings of the World Congress on Gastroenterology. Baltimore: Williams & Wilkins, 1958.
83. Korlitz BI. From Crohn to Crohn’s disease— 1979: an epidemiologic study in New York city. Mt Sinai J Med (NY) 1979;46:533-40.
84. Wright JP, Marks IN, Jameson C, et al. The Cape Town experience of Crohn’s disease. In: Lee ECG, ed. Crohn’s workshop: a global assessment of Crohn’s disease. London: HM & M Heyden, 1981:95-100.
85. Paulley JW. Ulcerative colitis: a study of 173 cases. Gastroenterology 1950;16:566.
86. Acheson ED. The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion. Gut 1960;1:91-3.
87. Rappaport H, Burgoyne FH, Smetana HF. The pathology of regional enteritis. Milit Surg 1951;109:463-502.
88. Monk M, Mendeloff AI, Siegel Cl, et al. An epidemiological study of ulcerative colitis and regional enteritis among adults in Baltimore. II. Social and demographic factors. Gastroenterology 1969;56:847-57.
89. Mendeloff AI, Monk M, Siegel Cl, et al. Illness experience and life stresses in patients with irritable colon and with ulcerative colitis. N Engl J Med 1970;282:14-17.
90. Singer HC, Anderson JGO, Fischer H, et al. Familial aspects of inflammatory bowel disease. Gastroenterology 1971;61:423-30.
91. Acheson ED, Nefzger MD. Ulcerative colitis in the US Army in 1944. Gastroenterology 1963;44:7-19.
92. Bonnevie O. A socio-economic study of patients with ulcerative colitis. Scand J Gastroenterol 1967;2:129-36.
93. Mayberry JF, Rhodes J, Newcombe RG. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn’s disease. Br Med J 1980; 1:84.
94. McConnell RB. Inflammatory bowel disease: newer views of genetic influences. In: Berk JE, ed. Developments in digestive disease. Vol 3. Philadelphia: Lea & Febiger, 1980:129-37.
95. Farmer RG, Michever WM, Mortimer EA. Studies of family history among patients with inflammatory bowel disease. Clin Gastroenterol 1980;9:271-8.
96. Whorwell PH, Eade OE, Hossenbocus A, et al. Crohn’s disease in a husband and wife. Lancet 1978;2:186-7.
97. Zetsel L. Crohn’s disease in a husband and wife. (Letter). Lancet 1978;2:583.
98. Craxi A, Olive L, Distefauo G. Ulcerative colitis in a married couple. Ital J Gastroenterol 1979;11:184-6.
99. O’Morain C, Smethurst P, Levi AJ, et al. Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn’s disease. J Clin Pathol 1983;36:1312-16.
100. O’Morain C, Smethurst P, Levi AJ, et al. Organelle pathology in ulcerative and Crohn’s colitis with special reference to the lysosomal alterations. Gut 1984;25:455-9.
101. Krosmeyer SJ, Williams RC, Wilson ID, et al. Lymphocytotoxic antibody in inflammatory bowel disease. N Engl J Med 1975;293:1117-20.
102. Podolsky DK, Isselbacher KJ. Glycoprotein composition of colonic mucosa: specific alteration in ulcerative colitis. Gastroenterology 1984;87:991- 8.
103. Roediger WEW. The colonic epithelium in ulcerative colitis: an energy-deficiency disease. Lancet 1980;2:712-15.
104. Price WH. A high incidence of chronic inflammatory bowel disease in patients with Turner’s syndrome. J Med Genet 1979;16:263-6.
105. Schinella RA, Creco MA, Gobert BL, et al. Hermansky-Pudlak syndrome with granulomatous colitis. Ann Intern Med 1980;92:20-3.
106. Nishimura H, Kino M, Kubo S, et al. Hashimo- to’s thyroiditis and ulcerative colitis in a patient with Turner’s syndrome. JAMA 1985;254:357.
107. Smolen JS, Gangl A, Potterauer P, et al. HLA antigens in inflammatory bowel disease. Gastroenterology 1982;82:34-8.
108. Pena AS, Biemond I, Kuiper G, et al. HLA antigen distribution and HLA haplotype segregation in Crohn’s disease. Tissue Antigens 1980;16:56-61.
109. Eade OE, Moulton C, Macpherson BR, et al. Discordant HLA haplotype segregation in familial Crohn’s disease. Gastroenterology 1980;79: 271-5.
110. Van den Berg-Loonen EM, Kekken-Saeys BJ, Meuwissen SGM, et al. Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel disease. J Immunogenet 1977;4:167-75.
111. Lyons DK, Postlethwaite RW. Chronic ulcerative colitis in twins. Gastroenterology 1948; 10:545-50.
112. Webb LR. The occurrence of chronic ulcerative colitis in two males. Gastroenterology 1950; 15:523-4.
113. Sleight DR, Galpin GE, Condon RE. Ulcerative colitis in female sibling. Gastroenterology 1971;61:507-12.
114. Sanford FE. Genetic implications in ulcerative colitis. Am J Surg 1971;37:512-17.
115. Fausa O, Fretheim B, Flatmark A, et al. Ulcerative colitis in monozygotic twins. Scand J Gastroenterol 1972;7(Suppl 16):38.
116. Gregg JA, Baggenstoss AH. Discordance for ulcerative colitis in identical twins concordant for cholestatic liver disease: report of two cases. Am J Dig Dis 1970;15:667-71.
117. Marie J, Ledoux-Lebard G. Rectocolitis: hemorragiques chez un enfant. Caractere familial de l’affection. Arch Mal l’Appar Dig Mal Nutr 1942;31:76-86.
118. Qazi QH, Pikin E, Fierst S. Discordant occurrence of ulcerative colitis in identical twins. Gastroenterology 1973;65:134-6.
119. Bacon HD. Ulcerative colitis. Philadelphia: Lippincott, 1958.
120. Finch SM, Hess JH. Ulcerative colitis in children. Am J Psychiatry 1962;9:819-26.
121. Binder V, Weeks E, Olson JH, et al. A genetic study of ulcerative colitis. Scand J Gastroenterol 1966;1:49-56.
122. Edwards HC. Regional enteritis: Crohn’s disease. In: Edwards HC, ed. Recent advances in surgery. 4th ed. London: J & A Churchill Ltd, 1954:1717.
123. Freysz H, Haemmerli A, Dartagener M. Ileitis regionalis bei einem weiblichen zwillinspaar. Gastroenterologia 1958;89:75-82.
124. Niederle MB. Regional ileitis in monozygotic female twins. Arch Mal l’Appar Dig Mal Nutr 1961;50:1245-6.
125. Hislop IG, Grant AK. Genetic tendency in Crohn’s disease. Gut 1969;10:994-5.
126. Crismer R, Dreze C, Donival P. Ileite de Crohn chez des jemeaux univitellins. Acta Genetica Med Gemellol (Roma) 1963;12:358-68.
127. Janowitz HD. Cited by Sherlock P, Bell BM, Steinberg H, et al. Familial occurrence of regional enteritis and ulcerative colitis. Gastroenterology 1963;45:413-20.
128. Anfanger H. Regional ileitis in children. J Mt Sinai Hosp 1955;22:187-91.
129. Tattersall RB, Pyke DA. Diabetes in identical twins. Lancet 1972;2:1120-5.
130. Schrumpf E, Fausa O, Forre O, et al. HLA antigens and immunoregulatory T-cells in ulcerative colitis associated with hepatobiliary disease. Scand J Gastroenterol 1982;17:187-91.
131. Farmer GW, Monroe MV, Fuccillo DA, et al.Viral investigations in ulcerative colitis and regional enteritis. Gastroenterology 1973;65:8-18.
132. Collins J, Jordan S, Zaia J, et al. No evidence of cytomegalovirus in ulcerative colitis tissue evaluated by culture, nucleic acid hybridization and monoclonal antibody. (Abstract). Gastroenterology 1985;88:1353.
133. Cave DR, Mitchell DN, Kane SP, et al. Further animal evidence of a transmissible agent in Crohn’s disease. Lancet 1973;2:1120.
134. Cave DR, Mitchell DN, Brooke BN. Observations on the transmissibility of Crohn’s disease and ulcerative colitis. (Abstract). Gut 1975; 16:401.
135. Orr MM, Tamarind DL, Cook J, et al. Chronic lesions of rabbit bowel due to contact with antiseptic skin preparation. (Abstract). Gut 1975; 16:401.
136. Bolton PM, Owen E, Heatley RV, et al. Negative findings in laboratory animals for a transmissible agent in Crohn’s disease. Lancet 1973;2:1122-4.
137. Parent K, Mitchell P. Cell wall-defective variants of Pseudomonas-like (Group Va) bacteria in Crohn’s disease. Gastroenterology 1978; 75:368-72.
138. Yoshimura HH, Markensich DC, Graham DY. Mycobacteria isolated from patients with Crohn’s disease. (Abstract). Gastroenterology 1985;88:1639.
139. Pena AS, Kuiper I, Walvoort HC, et al. Reproducibility of a potential serodiagnostic system in Crohn’s disease using primed nude mouse lymph nodes and the difference with lymphocytotoxic antibodies. (Abstract). Gastroenterology 1985; 88:1536.
140. Burnham WR, Lennard-Jones JE, Stanford JL, et al. Mycobacteria as a possible cause of inflammatory bowel disease. Lancet 1978;2:693-6.
141. Chiodini R, Van Kruiningen HJ, Merkal RS, et al. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn’s disease. J Clin Microbiol 1984;20:966-71.
142. Chiodini R, Van Kruiningen HJ, Thayer WR, et al. In vitro antimicrobial susceptibility of a Mycobacterium sp. isolated from patients with Crohn’s disease. Antimicrob Agents Chemother 1984;26:930-2.
143. Chiodini R, Van Kruiningen HJ, Thayer WR, et al. Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci 1984;29:1073-9.
144. Thayer WR, Coutu JA, Chiodini RJ, et al. Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn’s disease. Dig Dis Sci 1984;29:1080-5.
145. Chiodini RJ, Van Kruiningen HJ, Thayer WR, et al. Mycobacterial spheroplasts isolated from patients with Crohn’s disease. (Abstract). Gastroenterology 1985;88:1348.
146. Cho W, Brennan PJ, Yoshimura HH, et al. Mycobacterial etiology of Crohn’s disease: serologic study using common mycobacterial antigens and the species-specific glycolipid antigen from M. paratuberculosis. (Abstract). Gastroenterology 1985;88:1348.
147. Kruiningen HJ, Chiodini RJ, Thayer WR, et al. Experimental disease in goats induced by a Mycobacterium from a patient with Crohn’s disease. (Abstract). Gastroenterology 1985;88: 1623.
148. Gitnick G, Collins J, Beaman B, et al. Mycobacteria in Crohn’s disease. (Abstract). Gastroenterology 1985;88:1348.
149. Miller DS, Keighley A, Smith PG, et al. Crohn’s disease in Nottingham: a search for time-space clustering. Gut 1975;16:454-7.
150. Miller DS, Keighley A, Smith PG, et al. A case control method for seeking evidence of contagion in Crohn’s disease. Gastroenterology 1976; 71:385-7.
151. Hershfield NB. Crohn’s disease in a mother, father and son. Can Med Assoc J 1984;131:1190-1.
152. Kirsner JB, Shorter RG. Recent developments in “nonspecific” inflammatory bowel disease. (First of two parts). N Engl J Med 1982;306:775- 85.
153. Rosenberg JL, Kraft FC, Kirsner JB. Inflammatory bowel disease in all three members of one family. Gastroenterology 1976;70:759-60.
154. Achord JL, Gunn CH, Jackson JF. Regional enteritis and HLC concordance in multiple siblings. Dig Dis Sci 1982;27:330-2.
155. Kirsner JB. Genetic aspects of inflammatory bowel disease. Clin Gastroenterol 1973;2:557-75.
156. Helzer JE, Stillings WA, Chammas S, et al. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci 1982;27:513-18.
157. Gazzard BG, Price HL, Libby GW, et al. The social toll of Crohn’s disease. Br Med J 1978;2:1117-19.
158. National Research Council, National Academy of Sciences. Diet, nutrition, and cancer. Washington, DC: National Academy Press, 1982.
159. Minowa M, Bingham S, Cummings JH. Dietary fibre intake in Japan. Hum Nutr Appl Nutr 1983;32A:113.
160. Thornton JR, Emmett PM, Heaton KW. Diet and Crohn’s disease: characteristics of the preillness diet. Br Med J 1979;2:762-4.
161. O’Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. Br Med J 1984;288:1859-63.
162. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn’s disease with an unrefined- carbohydrate, fibre-rich diet. Br Med J 1979; 2:764-6.
163. Miller B, Fervers F, Rohbeck R, et al. Zuckerkonsum bie Patienten mit Morbus Crohn. Verh Dtsch Ges Inn Med 1976;82:922-4.
164. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn’s disease. Klin Wochenschr 1976;54:367-71.
165. Kasper H, Sommer H. Dietary fiber and nutrient intake in Crohn’s disease. Am J Clin Nutr 1979;32:1898-1901.
166. Thornton JR, Emmett PM, Heaton KW. Smoking, sugar, and inflammatory bowel disease. Br Med J 1985;290:1786-7.
167. Jarnerot G, Jarnmark I, Nilsson D. Consumption of refined sugar by patients with Crohn’s disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983;18:999-1002.
168. Truelove SC. Ulcerative colitis provoked by milk. Br Med J 1961;1:154-60.
169. Taylor DB, Truelove SC. Circulating antibodies to milk proteins in ulcerative colitis. Br Med J 1961;2:924-9.
170. Dudek B, Spiro HM, Thayer WR. A study of ulcerative colitis and circulating antibodies to milk proteins. Gastroenterology 1965;49:544-7.
171. Jewell DP, Truelove SC. Reaginic hypersensitivity in ulcerative colitis. Gut 1972;13:903-6.
172. James AH. Breakfast and Crohn’s disease. Br Med J 1977;1:943-5.
173. Rawcliffe PM, Truelove SC. Breakfast and Crohn’s disease. (Letter). Br Med J 1978;2:539-40.
174. Archer LNJ, Harvey RF. Breakfast and Crohn’s disease. (Letter). Br Med J 1978;2:540.
175. Mayberry JF, Rhodes H, Newcombe RG. Breakfast and dietary aspects of Crohn’s disease. Br Med J 1978;2:1401.
176. Acheson ED, Truelove SC. Early weaning in the aetiology of ulcerative colitis: a study of feeding in infancy in cases and controls. Br Med J 1961;2:929-33.
177. Whorwell PJ, Holdstock G, Whorwell GM, et al. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1979;1:382.
178. Hellers G. Some epidemiological aspects of Crohn’s disease in Stockholm county, 1955-1979. In: Pena AS, Weterman IT, Booth CC, et al, eds. Recent advances in Crohn’s disease. The Hague: Martinus Nijhoff, 1981:158-62.
179. Hirschman C, Sweet JA. Social background and breast feeding among American mothers. Soc Biol 1974;21:39-74.
180. Martinez GA, Nelezienski JP. The recent trend in breast feeding. Pediatrics 1979;64:686-90.
181. Zamcheck N, Broitman SA. Nutrition in diseases of the intestines. In: Goodhart RS, Shils ME, eds. Modern nutrition in health and disease. Philadelphia: Lea & Febiger, 1973:785-818.
182. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J 1982;284:706.
183. Logan RFA, Edmond M, Somerville KW, et al. Smoking and ulcerative colitis. Br Med J 1984;288:751-3.
184. Calkins B, Lilienfeld A, Mendeloff A, et al. Smoking factors in ulcerative colitis and Crohn’s disease in Baltimore. Am J Epidemiol 1984; 120:498.
185. Somerville KW, Logan RFA, Edmond M, et al. Smoking and Crohn’s disease. Br Med J 1984;289:954-6.
186. Bures J, Fixa B, Komarkova O, et al. Nonsmoking: a feature of ulcerative colitis. (Letter). Br Med J 1982;285:440.
187. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261-3.
188. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984;19:824-30.
189. Hanauer SB, Silverstein MD, Evans AA, et al. A case-control study of smoking in inflammatory bowel disease compared to the irritable bowel syndrome. (Abstract). Clin Res 1984;32:223.
190. Amery KV. Smoking and ulcerative colitis. (Letter). Br Med J 1984;288:1307.
191. Logan RFA, Langman MJS. Smoking and ulcerative colitis. (Letter). Br Med J 1984;288:1307.
192. Penny WJ, Penny E, Mayberry JF, et al. Mormons, smoking and ulcerative colitis. Lancet 1983;2:1315.
193. Gyde S, Prior P, Dew MJ, et al. Mortality in ulcerative colitis. Gastroenterology 1984;83:36-43.
194. Gyde SN, Prior P, Taylor K, et al. Cigarette smoking, blood pressure, and ulcerative colitis. Gut 1983;24:A998.
195. Gyde SN, Prior P, Alexander F, et al. Ulcerative colitis: why is the mortality from cardiovascular disease reduced? Q J Med 1984;77:351-7.
196. Roberts CJ, Diggle R. Non-smoking: a feature of ulcerative colitis. (Letter). Br Med J 1982; 285:440.
197. de Castella J. Non-smoking: a feature of ulcerative colitis. (Letter). Br Med J 1982;284:1706.
198. Holdstock G, Savage D, Harman M, et al. Should patients with inflammatory bowel disease smoke? Br Med J 1984;288:362.
199. Kols A, Rinehart W, Piotrow PT, et al. OCs— update on usage, safety, and side effects. Popul Rep (A) 1982;5:189-224.
200. Royal College of General Practitioners. Oral contraceptives and health. London: Pitman Medical, 1974.
201. Morowitz DA, Epstein BH. Spectrum of bowel disease associated with use of oral contraceptives. Med Ann Dist Colum 1973;42:6-10.
202. Bernardino ME, Lawson TL. Discrete colonic ulcers associated with oral contraceptives. Dig Dis Sci 1976;21:503-6.
203. Simon L, Figus 1A. Akut colitis ulcerosa-spontan regressiovai: a hormondis anticonceptio ujabb mellekhatasa? Orv Hetil 1976;117:2987-91.
204. Bonfds S, Hervior P, Girodet J, et al. Acute spontaneously recovering ulcerative colitis (ARUC). Am J Dig Dis 1977;22:429-36.
205. Favier D. Colite erosive chez des malades prenant des contraceptifs oraux. Nouv Presse Med 1977;6:2074.
206. Conri C, Schmitt B, Bache-Gabrielsen P, et al. Maladie de Crohn colique et contraception orale. Sem Hop Paris 1979;55:1733-5.
207. Camilleri M, Schafier K, Chadwick VS, et al. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology 1981;80:810-15.
208. Tedesco FJ, Volpicelli NA, More FS. Estrogen- and progesterone-associated colitis: a disorder with clinical and endoscopic features mimicing Crohn’s colitis. Gastrointest Endosc 1982; 28:247-9.
209. Rhodes JM, Cockel R, Allan RN, et al. Colonic Crohn’s disease and use of oral contraception. Br Med J 1984;288:595-6.
210. Lesko S, Kaufman D, Rosenberg L, et al. Oral contraceptive use and Crohn’s disease. (Abstract). Am J Epidemiol 1984;120:466.
211. Lesko SM, Kaufman DW, Rosenberg L, et al. Evidence for an increased risk of Crohn’s disease in oral contraceptive users. Gastroenterology 1985;89:1046-9.
212. Calkins BM, Mendeloff AI, Monk M, et al. Gastroenterology Unpublished data, 1985.
213. Dobbins WO. Dysplasia and malignancy in inflammatory bowel disease. Ann Rev Med 1984;35:33-48.
214. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Part IB. Carcinoma of the colon. Gut 1964;5:566-70.
215. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824-8.
216. MacDougall IPM. The cancer risk in ulcerative colitis. Lancet 1964;2:655-8.
217. Prior P, Gyde SN, Macartney JC, et al. Cancer morbitidy in ulcerative colitis. Gut 1982;23:490-7.
218. Bayless TM, Yardley JH. Cancer in inflammatory bowel disease. In: DeCosse JJ, Sherlock P, eds. Gastrointestinal cancer. I. The Hague: Mar- tinus Nijhoff, 1981:255-87.
219. Farmer RG. An appraisal of the cancer problem in ulcerative colitis. In: Korelitz BI, ed. Inflammatory bowel disease experience and controversy. Boston: John Wright, 1982:157-9.
220. Yardley JH, Bayless TM, Diamond MP. Cancer in ulcerative colitis. Gastroenterology 1979; 76:221-5.
221. Yardley JH, Ransohoff DF, Riddell RH, et al. Cancer in inflammatory bowel disease: how serious is the problem and what should be done about it? Gastroenterology 1983;85:197-9.
222. Bargen JA, Sauer WG, Sloan WP, et al. The development of cancer in chronic ulcerative colitis. Gastroenterology 1954;26:32-7.
223. Lennard-Jones JE, Morson BC, Ritchie JK, et al. Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology 1977;73:1280-9.
224. Dombal FT, Watts JMcK, Watkinson G, et al. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J 1966;1:1442-7.
225. Devroede GJ, Taylor WF, Sauer WG, et al. Cancer risk and life expectancy of children with ulcerative colitis. N Engl J Med 1971;285:17-21.
226. Welch CE, Hedberg SE. Colonic cancer in ulcerative colitis and idiopathic colon cancer. JAMA 1965;191:815-18.
227. Michener WM, Gage RP, Sauer WG, et al. The prognosis of chronic ulcerative colitis in children. N Engl J Med 1961;265:1075-9.
228. Barnes GL, Campbell PE, Chow CW, et al. Colectomy and cancer in Melbourne children with ulcerative colitis. Med J Aust 1980;2:84-7.
229. Skyring A, Roberts R. Childhood ulcerative colitis: an epidemiological study in NSW. Med J Aust 1965;1:955-60.
230. Bargen JA, Gage RP. Carcinoma in ulcerative colitis: prognosis. Gastroenterology 1960;39:385-93.
231. Aktan H, Paykoc Z, Ertan A. Ulcerative colitis in Turkey: clinical review of sixty cases. Dis Colon Rectum 1970;13:62-5.
232. Bonnevie O, Binder V, Anthonisen P, et al. The prognosis of ulcerative colitis. Scand J Gastroenterol 1974;9:81-91.
233. Storgaard L, Bischoff N, Henriksen FW, et al. Survival rate in Crohn’s disease and ulcerative colitis. Scand J Gastroenterol 1979;14:225-30.
234. Peltokallio P, Myllarniemi H. Ulcerative colitis and carcinoma of rectum and colon. Scand J Gastroenterol 1972;7(Suppl 17):70.
235. Gilat T, Zemishlany Z, Ribak J, et al. Ulcerative colitis in the Jewish population of Tel Aviv-Yafo. II. The rarity of malignant degeneration. Gastroenterology 1974;67:933-8.
236. Dennis C, Karlson KE. Cancer risk in ulcerative colitis: formidability per patient-year of late disease. Surgery 1961;50:568-71.
237. King RC, Lindner AE, Pollard HM. Chronic ulcerative colitis in childhood: a follow-up study. Arch Dis Child 1959;34:257-61.
238. Shorter RG. Risks of intestinal cancer in Crohn’s disease. Dis Colon Rectum 1983;26:686-9.
239. Greenstein AJ, Sachar DB, Smith H, et al. Patterns of neoplasia in Crohn’s disease and ulcerative colitis. Cancer 1980;46:403-7.
240. Greenstein AJ, Sachar DB, Smith H, et al. A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 1981;48:2742-5.
241. Schofield PF. Intestinal malignancy and Crohn’s disease. Proc R Soc Med 1972;65:783-4.
242. Prior P, Gyde SN, Macartney JC, et al. Malignancy in Crohn’s disease. Gut 1980;21:1024-9.
243. Korlitz BI. Carcinoma of the intestinal tract in Crohn’s disease: results of a survey conducted by the National Foundation for Ileitis and Colitis. (Editorial). Am J Gastroenterol 1983;78:59-60.
244. Warren R, Barwick KW. Crohn’s colitis with carcinoma and dysplasia. Report of a case and review of 100 small and large bowel resections for Crohn’s disease to detect incidence of dysplasia. Ann J Surg Pathol 1983;7:151-9.
245. Prior P. Malignancy in Crohn’s disease. Br J Prev Soc Med 1972;26:44-6.
246. Fielding JR, Prior P, Waterhouse JA, et al. Malignancy in Crohn’s disease. Scand J Gastroenterol 1972;7:3-7.
247. Butt JH, Morson BC. Dysplasia and cancer in inflammatory bowel disease. (Editorial). Gastroenterology 1981;80:865-8.
248. Hamilton SR. Colorectal carcinoma in patients with Crohn’s disease. Gastroenterology 1985;89:398-407.
249. Lennard-Jones JE. The clinical outcome of ulcerative colitis depends on how much of the colonic mucosa is involved. Scand J Gastroenterol 1983;18(Suppl 88):48-53